EXPERIMENTAL STUDY OF THE TOXICITY AND HAZARD OF QUETIAPINE FUMARATE
- Авторлар: Golubeva M.I.1, Bidevkina М.V.2, Bobrineva I.A.1, Razumnaya I.N.1, Fedorova E.A.1, Savchenko A.Y.3, Ramenskaya G.V.4, Pozharnov I.A.5
-
Мекемелер:
- All-Union Scientifi c Center for the Safety of Biologically Active Substances
- Scientifi c Research Institute of Disinfectology of Rospotrebnadzor
- Scientifi c Center of Biomedical Technologies of the Federal Medical Biological Agency
- I.M. Sechenov First Moscow State Medical University, RF Ministry of Health
- AstraZeneca Industries LLC
- Шығарылым: № 6 (2020)
- Беттер: 54-58
- Бөлім: New information on toxicity and hazard of chemical and biological substances
- ##submission.datePublished##: 04.01.2021
- URL: https://rjpbr.com/0869-7922/article/view/641268
- DOI: https://doi.org/10.36946/0869-7922-2020-6-54-58
- ID: 641268
Дәйексөз келтіру
Толық мәтін
Аннотация
Негізгі сөздер
Авторлар туралы
M. Golubeva
All-Union Scientifi c Center for the Safety of Biologically Active Substances
Хат алмасуға жауапты Автор.
Email: golubevamargo@mail.ru
Golubeva Margarita Ivanovna
142450, Staraya Kupavna, Moscow region
РесейМ. Bidevkina
Scientifi c Research Institute of Disinfectology of Rospotrebnadzor
Email: bidevkinamv@niid.ru
Bidevkina Marina Vasil’evna
117246, Moscow
РесейI. Bobrineva
All-Union Scientifi c Center for the Safety of Biologically Active Substances
Email: ural955@mail.ru
Bobrineva Irina Alekseevna
142450, Staraya Kupavna, Moscow region
РесейI. Razumnaya
All-Union Scientifi c Center for the Safety of Biologically Active Substances
Email: irina.r.3@mail.ru
Razumnaja Irina Nikolaevna
142450, Staraya Kupavna, Moscow region
РесейE. Fedorova
All-Union Scientifi c Center for the Safety of Biologically Active Substances
Email: emfed@mail.ru
Fedorova Emma Alexeеvna
142450, Staraya Kupavna, Moscow region
РесейA. Savchenko
Scientifi c Center of Biomedical Technologies of the Federal Medical Biological Agency
Email: alursav@mail.ru
Savchenko Аlla Jur’evna
143442, Moscow region
РесейG. Ramenskaya
I.M. Sechenov First Moscow State Medical University, RF Ministry of Health
Email: ramenskaia@mail.ru
Ramenskaya Galina Vladislavovna
119991, Moscow
РесейI. Pozharnov
AstraZeneca Industries LLC
Email: pozharnov@mail.ru
Pozharnov Igor Anatol’evich
249006, Kaluga region, Borovsky district, Dobrino village
РесейӘдебиет тізімі
- Burchinsky S.G. Problem of safety in the strategy of pharmacotherapy with atypical neuroleptics. Neuro News: Psychoneurology and neuropsychiatry. 2010; 5 (24). Available at: https:// neuronews.com.ua/ru/issuearticle-337/Problema-bezopasnostiv-strategii-farmakoterapii-atipichnymineyroleptikami#gsc.tab=0. Date of access 08.08.2019 (in Russian).
- Maksimov V.I. Quetiapine and its place in the treatment of various diseases among the atypical psicoticos. Modern therapy of mental disorders. 2009, (2): 24-30 (in Russian).
- Davydov A.T., Petrova N.N., Agishev V.G. Role and place of atypical antipsychotic drugs in psychiatric practice (current state of the problem). Reviews of clinical pharmacology and drug therapy. 2005, 4 (1): 38-48 (in Russian).
- Mazo G.E., Ivanov M.V., Chomsky A.N., Lukmanova K.A. Risk of metabolic disorders in patients with schizophrenia when using atypical antipsychotics (review of literature data). Modern therapy of mental disorders. 2008, (1): 15-19 (in Russian).
- http://www.scribd.com/doc/3553710/ SEROQUEL-quetiapine-fumarate-ProductMonograph-for-Canada. Date of Revision: May 21 2008. Date of access 08.08.2019 (in Russian).
Қосымша файлдар
